Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network
The blood draw process is quick and efficient, and can be done at any labcorp facility
GHK-Cu is a naturally occurring plasma peptide Size : BPC-157 is a 15-amino acid peptide (1419.53 Da)
Limited Clinical Safety Data : The human safety profile remains unclear because the evidence is primarily based on animal and laboratory studies rather than large-scale clinical trials
After digestion and metabolism, less than 5% of the effect can be exerted, and the cosmetic effect is minimal
The FDA has expressed particular concerns about compounded medications because they often lack the necessary oversight that ensures consistent quality
